Correlation Between Zentalis Pharmaceuticals and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and AN2 Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and AN2 Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and AN2 Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zentalis and AN2 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and AN2 Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the AN2 Therapeutics. In addition to that, Zentalis Pharmaceuticals is 1.07 times more volatile than AN2 Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 210.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would lose (43.00) from holding AN2 Therapeutics or give up 20.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. AN2 Therapeutics
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| AN2 Therapeutics |
Zentalis Pharmaceuticals and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and AN2 Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |